Maximising Returns with Portfolio Manager James McDonald

In this interview, Executive Director Adam Myers talks strategy and success with James McDonald, the Portfolio Manager for the Pengana High Conviction Equities Fund.

James discusses the Fund’s exceptional year, emphasising the strategic investments in companies like Telix Pharmaceuticals and Clarity Pharmaceuticals in the healthcare sector, and IperionX and Brazilian Rare Earths in the materials sector, which have significantly contributed to the fund’s performance.

He also details the fund’s focus on ethical and ESG considerations, ensuring investments are both profitable and responsible. Additionally, James shares his optimism about the fund’s future, citing the potential for ongoing value in overlooked or undervalued companies that exhibit strong growth prospects.

Key Takeaways:

  • Strong Performance: The fund has significantly outperformed the general market, thanks to a highly selective, global high conviction investment strategy limited to 20 holdings.
  • Strategic Investment Focus: Investments are chosen based on sustainable competitive advantages and intrinsic value, focusing on sectors like healthcare and materials where the fund has deep expertise.
  • Ethical and ESG Integration: The fund applies a negative ethical screen and integrates Environmental, Social, and Governance (ESG) criteria to ensure investments are beneficial to society and the environment.
  • Opportunities in Undervalued Assets: James emphasises the fund’s success in identifying undervalued companies that are under-researched or out of favor, particularly smaller companies with high growth potential.
  • Optimistic Outlook: Despite recent successes, James sees continued opportunities for investment across various sectors, indicating a positive outlook for the fund’s future performance.

Get monthly insights and market commentary direct to your inbox

Pengana Capital Group